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sion. However, asymptomatic meniscal lesions are common and frequent
incidental ﬁndings on knee MRI of the middle-aged or older patient.
Even though meniscal lesions cannot be viewed as an innocent bystander,
its linkage with knee symptoms is complex. Other knee pathologies than
meniscus tears may often be the direct cause of knee pain. Further, the high
frequency of meniscal pathology in the general population challenges the
health professional in choosing the best treatment in the short- and long-
term. A meniscal tear can lead to knee OA by increased focal biomechanical
loading, but knee OA can also lead to meniscal tear. A degenerative menis-
cal lesion in the middle-aged or older patient could suggest early-stage
pre-radiographic knee OA and should be treated accordingly. The need for
surgical treatment of stable degenerative meniscal lesions in knees with
or without OA is often doubtful and evidence of a beneﬁcial effect above
placebo is so far lacking. Surgical resection of stable meniscal lesions is not
expected to improve meniscal functioning.
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Purpose: Osteoarthritis (OA) is one the most common forms of joint dis-
ease in humans and companion animals. The management of OA primarily
focuses on symptomatic pain relief using analgesics and non-steroidal
anti-inﬂammatory drugs (NSAIDs). However, pharmacotherapy with con-
ventional drugs does not inﬂuence the course of disease progression and
is associated with signiﬁcant side effects in other organ systems. Conse-
quently, there is an acute need for developing safer alternative remedies
for OA. Self-management, complementary and alternative medicine strate-
gies are receiving increasing attention from patients, practitioners and
researchers. There are many biological pathways and molecular mech-
anisms by which dietary and nutritional factors might be expected to
exert favourable inﬂuences on pathophysiological processes in cartilage
and synovium in OA. However, these are poorly understood and the quality
and consistency of research on dietary supplements and nutraceuticals has
been variable. Research in our laboratory has focussed on testing a range
of botanicals and nutritional supplements in vitro. Our current objective is
to apply high throughput post-genomic techniques to identify the major
biomarkers present in the secretome of articular cartilage and monitor
responses to pro-inﬂammatory and anti-inﬂammatory stimuli.
Methods: We have established in vitro models of canine and equine
cartilage for screening plant-derived phytochemicals such as curcumin
and cocktails of plant extracts for anti-inﬂammatory activity. Our pre-
ferred model uses cartilage explants and incorporates viability and cy-
totoxicity assays (LIVE/DEAD®) as well as glycosaminoglycan (GAG) and
prostaglandin E2 (PGE2) release assays for assessing in vitro responses
to pro-inﬂammatory cytokines, NSAIDs, nutraceuticals and plant extracts.
We have also developed high throughput proteomic techniques to map
the secretome and identify a set of biomarkers for assessing extracellular
matrix turnover.
Results: Cell viability, GAG and PGE2 release appear to be consistent and
robust parameters for assessing the safety and anti-inﬂammatory activity
of NSAIDs, plant extracts and dietary supplements on cartilage explants
in vitro. The biomarkers identiﬁed from the secretome of both species
include cartilage oligomeric matrix protein (COMP) a well established
prognostic indicator and disease marker as well as ﬁbronectin, biglycan,
chondroadherin (CHAD), matrix metalloproteinases 1 and 3 (MMP-1, MMP-
3), clusterin, decorin, thrombospondins 1 and 4 (TSP-1, TSP-4), cartilage
intermediate layer protein -1 (CILP-1) and aggrecan core protein.
Conclusions: Dietary supplementation may well have a role in inﬂuencing
the course of OA progression. However, the scientiﬁc and medical commu-
nity remains skeptical about the eﬃcacy of nutritional supplementation for
OA despite their broad acceptance and use by patients. New and innovative
approaches are needed to gain a better understanding of the response to
NSAIDs and dietary supplements that claim to have anti-inﬂammatory ac-
tivity. Our work suggests that 3-dimensional culture systems may be used
to screen for anti-inﬂammatory activity in extracts of dietary supplements.
This approach combines viability/cytotoxicity tests, biochemical assays and
proteomics. We are currently validating quantitative western blot assays
for measuring changes in the levels of the protein biomarkers identiﬁed in
the cartilage secretome in response to inﬂammatory and anti-inﬂammatory
stimuli. We are also hoping to set up multiplex assays for other inﬂamma-
tory mediators. Once established, these assays may be applied to synovial
ﬂuid and serum samples from animals on clinical or ﬁeld trials of dietary
supplements. Whether dietary supplements can be effectively and safely
recommended to reduce NSAID usage is still unclear and requires more
rigorous research. Multi-disciplinary approaches that combine hypothesis
driven and well-designed basic, clinical and epidemiological studies should
help us make better-informed decisions about the beneﬁts of dietary
supplements in OA therapy.
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The obstacles to overcome in rehabilitation of osteoarthritis must reﬂect
both the eliciting factors and practical issues with the implementation of
the program. The biomechanics of the knee may be the key to understand-
ing progression of knee OA. However, in a setting with varying degree of
joint destruction, pain, and loss of muscle strength, all three factors should
be considered by the therapist. On top of this, rehabilitation is an art of
interpersonal relationships.
It is very diﬃcult to sort out the best strategy for maintaining rehabil-
itation in patients with painful degenerative diseases [1]. The chance of
a rehabilitation program increases with the enthusiasm of both patient
and therapist. This evasive factor may to some extent be supported by
participation in a trial.
Before exercise - weight loss? While it is debated whether increased
weight per se may cause OA [2], once there, the weight seems to be
a decisive factor for progression, biomechanically driven by increased
joint loads, e.g. assesses by the knee adduction moment [3]. Weight may
inﬂuence gait by changes in peak adduction moment, muscle strength and
walking distance.
During exercise - treating the pain? To participate in e.g. exercises for a
painful disease, it must be considered whether the level of pain should
guide the therapy. This is all the more relevant as exercises may induce a
deterioration of the OA in some cases [4]. In favour of this strategy is the
central inhibition of muscle function [5]. On the other hand, reduction of
pain may cause changes in gait pattern with a potential for joint destruction
[6].
The interesting question is, whether a knee may become too bad for
exercise, i.e. if there is a ‘point-of-no-return’ for knee OA, with a unde-
sirable response in joint loading to pain at advanced stages of disease
(Henriksen et al. submitted). The interaction between structural changes,
pain, joint loadings and muscle function must be explored to improve
clinical outcomes of rehabilitation programmes.
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